OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
February 17, 2021
The acquisition will integrate drug substance, drug product, and clinical testing capabilities under Quotient.
February 02, 2021
CDMOs address the unique challenges of liquid and lyophilized forms as well as preparing for the large capacity needed for COVID-19 vaccines.
September 23, 2020
CMDO Piramal Pharma Solutions held a grand opening at a facility they acquired in Sellersville, PA.
August 14, 2020
Experts at Hovione describe progress being made in understanding how to optimize continuous processes for oral solid-dosage drug products.
July 08, 2020
The acquisition will give the CDMO additional clinical filling options in Europe, which is expected to come online in 2021.
May 19, 2020
HHS announces $354 million in funding for private industry to manufacture generic drugs in the US from raw materials to finished product.
April 30, 2020
Catalent and Johnson & Johnson announce joint investment and tech transfer to prepare for rapid scale-up and segregated cGMP commercial manufacturing capacity.
April 23, 2020
Catalent Biologics increased capacity at its Bloomington, IN Facility.
April 15, 2020
Civica Rx plans redundant manufacturing capacity to relieve and prevent shortages of generic, sterile injectable drugs.
April 02, 2020
Considering the potential interaction of a drug with the delivery device early on in in development is integral to achieving the best combination.